184 related articles for article (PubMed ID: 21827726)
1. On the use of abciximab in percutaneous coronary intervention.
Iversen AZ
Dan Med Bull; 2011 Aug; 58(8):B4312. PubMed ID: 21827726
[No Abstract] [Full Text] [Related]
2. Abciximab and atherosclerotic heart disease: use in percutaneous coronary intervention, acute coronary syndromes and acute myocardial infarction.
Gum PA; Lincoff AM
Int J Clin Pract; 2003; 57(1):43-8. PubMed ID: 12587942
[TBL] [Abstract][Full Text] [Related]
3. Double vessel occlusions after balloon angioplasty treated by stenting and subsequently by abciximab infusion.
Bertrand OF; Meerkin D; de Guise P; Crépeau J; Bourassa MG
Can J Cardiol; 2000 Jan; 16(1):83-5. PubMed ID: 10653937
[TBL] [Abstract][Full Text] [Related]
4. Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Guagliumi G; Stone GW; Cox DA; Stuckey T; Tcheng JE; Turco M; Musumeci G; Griffin JJ; Lansky AJ; Mehran R; Grines CL; Garcia E
Circulation; 2004 Sep; 110(12):1598-604. PubMed ID: 15353506
[TBL] [Abstract][Full Text] [Related]
5. [The role of abciximab in the prevention of the acute thrombotic complications of coronary angioplasty].
Mesquita A; Baptista J; Almeida M; Ferreira J; Machado F; Palos L; Silva A; Seabra-Gomes R
Rev Port Cardiol; 1997 Dec; 16(12):1031-5. PubMed ID: 9522626
[No Abstract] [Full Text] [Related]
6. Prospective evaluation of early abciximab and primary percutaneous intervention for patients with ST elevation myocardial infarction complicated by cardiogenic shock: results of the REO-SHOCK trial.
Zeymer U; Tebbe U; Weber M; Vohringer HF; Jaksch R; Bischoff KO; Toepel W; Marsalek P; Horn S; Neuhaus KL;
J Invasive Cardiol; 2003 Jul; 15(7):385-9. PubMed ID: 12840235
[TBL] [Abstract][Full Text] [Related]
7. Abciximab and percutaneous coronary intervention: new indications. Medium-term benefit.
Prescrire Int; 2000 Apr; 9(46):36-8. PubMed ID: 11503782
[TBL] [Abstract][Full Text] [Related]
8. The use of abciximab during percutaneous coronary angioplasty reduces ischaemic events, but the cost is prohibitive.
Mayosi BM; Latouf SE; Commerford PJ
S Afr Med J; 1998 Feb; 88(2):130-1. PubMed ID: 9717492
[No Abstract] [Full Text] [Related]
9. Coronary artery stenting during acute myocardial infarction in patients treated with IIb/IIIa anti-platelet antibodies: early outcome results.
Murdock DK; Hoffman MT; Logemann TN; Kaufman JS; Engelmeier RS
Wis Med J; 1996 Dec; 95(12):867-71. PubMed ID: 8993226
[TBL] [Abstract][Full Text] [Related]
10. Coronary stenting and abciximab in primary angioplasty for ST-segment-elevation myocardial infarction.
De Luca G; Suryapranata H; Grimaldi R; Chiariello M
QJM; 2005 Sep; 98(9):633-41. PubMed ID: 16040669
[TBL] [Abstract][Full Text] [Related]
11. Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
Tcheng JE; Kandzari DE; Grines CL; Cox DA; Effron MB; Garcia E; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Fahy M; Lansky AJ; Mehran R; Stone GW;
Circulation; 2003 Sep; 108(11):1316-23. PubMed ID: 12939213
[TBL] [Abstract][Full Text] [Related]
12. Instant dissolution of intracoronary thrombus by abciximab.
Lee CH; Ho KT; Tan HC
Int J Cardiol; 2005 Sep; 104(1):102-3. PubMed ID: 16137518
[TBL] [Abstract][Full Text] [Related]
13. Abciximab in the treatment of ST-segment elevation myocardial infarction.
Tan DS; Sim DK; Chan ES; Tan RS
JAMA; 2005 Oct; 294(14):1760-1; author reply 1761. PubMed ID: 16219877
[No Abstract] [Full Text] [Related]
14. Prehospital versus periprocedural abciximab in ST-elevation myocardial infarction treated by percutaneous coronary intervention.
Pels K; Schröder J; Witzenbichler B; Müller D; Morguet A; Pauschinger M; Schultheiss HP; Arntz HR
Eur J Emerg Med; 2008 Dec; 15(6):324-9. PubMed ID: 19078834
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
[TBL] [Abstract][Full Text] [Related]
16. [Gastrointestinal bleeding in a patient with acute myocardial infarction treated with primary coronary angioplasty and abciximab (ReoPro) administration].
Gziut AI; Pastwa Ł; Słysz A
Kardiol Pol; 2006 Mar; 64(3):334-6; discussion 337-8. PubMed ID: 16583343
[No Abstract] [Full Text] [Related]
17. Glycoprotein IIb/IIIa receptor inhibitors in 2008: do they still have a role?
Mukherjee D; Roffi M
J Interv Cardiol; 2008 Apr; 21(2):118-21. PubMed ID: 18384343
[No Abstract] [Full Text] [Related]
18. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
[TBL] [Abstract][Full Text] [Related]
19. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction.
Stone GW; Grines CL; Cox DA; Garcia E; Tcheng JE; Griffin JJ; Guagliumi G; Stuckey T; Turco M; Carroll JD; Rutherford BD; Lansky AJ;
N Engl J Med; 2002 Mar; 346(13):957-66. PubMed ID: 11919304
[TBL] [Abstract][Full Text] [Related]
20. Mortality at 1 year for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularization: do tirofiban and ReoPro give similar efficacy outcomes at trial 1-year follow-up.
Mukherjee D; Topol EJ; Bertrand ME; Kristensen SD; Herrmann HC; Neumann FJ; Yakubov SJ; Bassand JP; McClure RR; Stone GW; Ardissino D; Moliterno DJ;
Eur Heart J; 2005 Dec; 26(23):2524-8. PubMed ID: 16107485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
